FAGR Fagron SA

Disclosure of received notification of Norges Bank

Disclosure of received notification of Norges Bank

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 19 October 2020

Disclosure of received notification of Norges Bank

Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received a notification of Norges Bank.

Notification of Norges Bank

  • On 13 October 2020, Fagron received a notification of Norges Bank that the total position (voting rights and equivalent financial instruments) had fallen below the disclosure threshold of 3% (the lowest threshold) on 12 October 2020 as the result of the disposal of voting securities or voting rights.
12 October 2020    
Voting rights 2,142,679 2.97%
Equivalent financial instruments (right to recall) 19,729 0.03%
Total number of voting rights 2,162,408 2.9959%
  • The notification of Norges Bank can be viewed on  via this .

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information

Constantijn van Rietschoten

Chief Communications Officer

Tel. 85

Please open the link below for the press release:

EN
19/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

 PRESS RELEASE

Fagron publishes its Annual Report 2025

Fagron publishes its Annual Report 2025 Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2026 7AM CET Fagron publishes its Annual Report 2025 Fagron, the leading global player in pharmaceutical compounding, today publishes its Annual Report 2025, further to its earlier announcement of Fagron's annual financial results for the financial year 2025 on February 12, 2026. The Annual Report is available on Fagron's in both Dutch (official version, including the ESEF-tagged version) and English. It comprises the annual financial report relating to the consolidated f...

 PRESS RELEASE

Fagron publiceert haar Jaarverslag 2025

Fagron publiceert haar Jaarverslag 2025 Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 6 maart 2026 – 7:00 CET Fagron publiceert haar Jaarverslag 2025 Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, publiceert vandaag haar Jaarverslag 2025, volgend op de eerdere bekendmaking van Fagron's jaarlijkse financiële resultaten over het boekjaar 2025 op 12 februari 2026.  Het Jaarverslag is beschikbaar op de van Fagron in zowel het Nederlands (officiële versie, inclusief ESEF-getagde versie) als in het Engels. Het Jaarverslag omvat het financieel...

 PRESS RELEASE

Fagron completes acquisition of Vepakum

Fagron completes acquisition of Vepakum Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 3 March 2026 – 7:00AM Fagron completes acquisition of Vepakum Fagron, the leading global player in pharmaceutical compounding, announces the successful completion of its acquisition of Vepakum in Latin America. The transaction, announced in December 2025, was finalized following regulatory clearance from CADE in early February 2026. Vepakum operates two facilities in São Paulo, Brazil, and specializes in high-quality pharmaceutical packaging solutions. The ac...

 PRESS RELEASE

Fagron voltooit overname van Vepakum

Fagron voltooit overname van Vepakum Gereglementeerde informatie - voorwetenschapNazareth (België)/Rotterdam (Nederland), 3 maart 2026 – 7:00 Fagron voltooit overname van Vepakum Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, maakt bekend dat de overname van Vepakum in Latijns-Amerika succesvol is afgerond. De transactie, die in december 2025 werd aangekondigd, kon worden voltooid nadat CADE, de Braziliaanse mededingingsautoriteit, in februari 2026 goedkeuring verleende. Vepakum beschikt over twee productiefaciliteiten in São Paulo, Brazilië, en is gespecial...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch